{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:49:39Z","timestamp":1782604179275,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s10157-019-01799-2","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T04:49:24Z","timestamp":1571806164000},"page":"136-142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Long-term follow-up characteristics of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) receiving chronic hemodialysis at a single center"],"prefix":"10.1007","volume":"24","author":[{"given":"Yoei","family":"Miyabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Karasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomo","family":"Takabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Kyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobue","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Hanafusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Tuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosaku","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"key":"1799_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"J Jennette","year":"2013","unstructured":"Jennette J, Falk R, Bacon P, Basu N, Cid M, Ferrario F, et al. 2012 Revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65:1\u201311.","journal-title":"Arthritis Rheum"},{"key":"1799_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"CJ Jennette","year":"1994","unstructured":"Jennette CJ, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Arthritis Rheum. 1994;37:187\u201392.","journal-title":"Arthritis Rheum"},{"key":"1799_CR3","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/ki.2009.218","volume":"76","author":"S Lionaki","year":"2009","unstructured":"Lionaki S, Hogan SL, Jennette CE, Hu Y, Hamra JB, Jennette CJ, et al. The clinical course of ANCA small-vessel vasculitis on chronic dialysis. Kidney Int. 2009;76:644\u201351.","journal-title":"Kidney Int."},{"key":"1799_CR4","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.2215\/CJN.01461005","volume":"1","author":"S Fujimoto","year":"2006","unstructured":"Fujimoto S, Uezono S, Hisanaga S, Fukudome K, Kobayashi S, Suzuki K, et al. Incidence of ANCA-associated primary renal vasculitis in the Miyazaki prefecture: the first population-based, retrospective, epidemiologic survey in Japan. Clin J Am Soc Nephrol. 2006;1:1016\u201322.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1799_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3899\/jrheum.160005","volume":"44","author":"S Furuta","year":"2016","unstructured":"Furuta S, Chaudhry AN, Arimura Y, Dobashi H, Fujimoto S, Homma S, et al. Comparison of the phenotype and outcome of granulomatosis with polyangiitis between UK and Japanese cohorts. The Journal of Rheumatology. 2016;44:216\u201322.","journal-title":"The Journal of Rheumatology."},{"key":"1799_CR6","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3899\/jrheum.131038","volume":"41","author":"AJ Mohammad","year":"2014","unstructured":"Mohammad AJ, Segelmark M. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis. J Rheumatol. 2014;41:1366\u201373.","journal-title":"J Rheumatol."},{"issue":"1","key":"1799_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/annrheumdis-2013-203927","volume":"74","author":"Joanna Robson","year":"2013","unstructured":"Robson J, Doll H, Suppiah R, Flossmann O, Harper L, H\u00f6glund P, et al. Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials. Ann Rheumat Dis 2013;74:2013\u2013203927.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"1799_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10157-012-0651-1","volume":"17","author":"K Sugiyama","year":"2013","unstructured":"Sugiyama K, Sada K, Kurosawa M, Wada J, Makino H. Current status of the treatment of microscopic polyangiitis and granulomatosis with polyangiitis in Japan. Clin Exp Nephrol. 2013;17:51\u20138.","journal-title":"Clin Exp Nephrol"},{"key":"1799_CR9","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","volume":"75","author":"M Yates","year":"2016","unstructured":"Yates M, Watts R, Bajema I, Cid M, Crestani B, Hauser T, et al. EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;75:1583.","journal-title":"Ann Rheum Dis"},{"key":"1799_CR10","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","volume":"371","author":"L Guillevin","year":"2014","unstructured":"Guillevin L, Pagnoux C, Karras A, Khouatra C, Auma\u00eetre O, Cohen P, et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med. 2014;371:1771\u2013800.","journal-title":"N Engl J Med."},{"key":"1799_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s13075-015-0815-y","volume":"17","author":"K Sada","year":"2015","unstructured":"Sada K, Yamamura M, Harigai M, Fujii T, Takasaki Y, Amano K, et al. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study. Arthritis Res Ther. 2015;17:305.","journal-title":"Arthritis Res Ther."},{"key":"1799_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/ard.2006.054593","volume":"66","author":"R Watts","year":"2007","unstructured":"Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66:222.","journal-title":"Ann Rheum Dis"},{"key":"1799_CR13","doi-asserted-by":"crossref","unstructured":"Moiseev S, Novikov P, Jayne D, Mukhin N. End-stage renal disease in ANCA-associated vasculitis. Nephrol Dial Transpl. 2016;32:gfw046.","DOI":"10.1093\/ndt\/gfw046"},{"key":"1799_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3109\/14397595.2015.1045255","volume":"26","author":"M Hasegawa","year":"2015","unstructured":"Hasegawa M, Hattori K, Sugiyama S, Asada H, Yamashita H, Takahashi K, et al. A retrospective study on the outcomes of MPO-ANCA-associated vasculitis in dialysis-dependent patients. Mod Rheumatol. 2015;26:110\u20134.","journal-title":"Mod Rheumatol"},{"key":"1799_CR15","doi-asserted-by":"publisher","first-page":"598","DOI":"10.2169\/internalmedicine.40.598","volume":"40","author":"K Okano","year":"2001","unstructured":"Okano K, Yumura W, Nitta K, Uchida K, Ohnuki T, Kawashima A, et al. Analysis of lupus activity in end-stage renal disease treated by hemodialysis. Intern Med. 2001;40:598\u2013602.","journal-title":"Intern Med"},{"key":"1799_CR16","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/ndt\/13.7.1713","volume":"13","author":"M Haubitz","year":"1998","unstructured":"Haubitz M, Koch K, Brunkhorst R. Survival and vasculitis activity in patients with end-stage renal disease due to Wegener\u2019s granulomatosis. Nephrol Dial Transplant. 1998;13:1713\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"1799_CR17","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1681\/ASN.V10102171","volume":"10","author":"B Memoli","year":"1999","unstructured":"Memoli B, Marzano L, Bisesti V, Andreucci M, Guida B. Hemodialysis-related lymphomononuclear release of interleukin-12 in patients with end-stage renal disease. J Am Soc Nephrol JASN. 1999;10:2171\u20136.","journal-title":"J Am Soc Nephrol JASN."},{"key":"1799_CR18","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1093\/ndt\/gfl415","volume":"21","author":"G Banche","year":"2006","unstructured":"Banche G, Allizond V, Giacchino F, Mandras N, Roana J, Bonello F, et al. Effect of dialysis membrane biocompatibility on polymorphonuclear granulocyte activity in dialysis patients. Nephrol Dial Transplant. 2006;21:3532\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"1799_CR19","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/ki.1992.105","volume":"41","author":"CA Dinarello","year":"1992","unstructured":"Dinarello CA. Cytokines: Agents provocateurs in hemodialysis? Kidney Int. 1992;41:683\u201394.","journal-title":"Kidney Int"},{"key":"1799_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1525-139X.2006.00175.x","volume":"19","author":"M Chonchol","year":"2006","unstructured":"Chonchol M. HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: neutrophil dysfunction and infection risk in end-stage renal disease. Semin Dial. 2006;19:291\u20136.","journal-title":"Semin Dial"},{"key":"1799_CR21","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1681\/ASN.V391541","volume":"3","author":"R Vanholder","year":"1993","unstructured":"Vanholder R, Ringoir S. Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review. J Am Soc Nephrol JASN. 1993;3:1541\u201354.","journal-title":"J Am Soc Nephrol JASN."},{"issue":"8","key":"1799_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","volume":"10","author":"J. Charles Jennette","year":"2014","unstructured":"Jennette CJ, Falk RJ. Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol. 2014;10:nrrheum.2014.103.","journal-title":"Nature Reviews Rheumatology"},{"key":"1799_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1681\/ASN.2013111233","volume":"26","author":"MJ Kemna","year":"2015","unstructured":"Kemna MJ, Damoiseaux J, Austen J, Winkens B, Peters J, van Paassen P, et al. ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease. J Am Soc Nephrol. 2015;26:537\u201342.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"1799_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/qjmed\/hcu043","volume":"107","author":"M. Romeu","year":"2014","unstructured":"Romeu M, Couchoud C, Delarozi\u00e8re J-C, Burtey S, Chiche L, Harl\u00e9 J-R, et al. Survival of patients with ANCA-associated vasculitis on chronic dialysis: data from the French REIN registry from 2002 to 2011. QJM. 2014;107:545\u201355.","journal-title":"QJM: An International Journal of Medicine"},{"key":"1799_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/j.ajkd.2007.04.018","volume":"50","author":"F Weidanz","year":"2007","unstructured":"Weidanz F, Day CJ, Hewins P, Savage CO, Harper L. Recurrences and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis. Am J Kidney Dis. 2007;50:36\u201346.","journal-title":"Am J Kidney Dis"},{"key":"1799_CR26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2215\/CJN.05610611","volume":"7","author":"JG McGregor","year":"2012","unstructured":"McGregor JG, Hogan SL, Hu Y, Jennette CE, Falk RJ, Nachman PH. Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease. Clin J Am Soc Nephrol. 2012;7:240\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"1799_CR27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3899\/jrheum.110705","volume":"39","author":"TAKASHI WADA","year":"2011","unstructured":"Wada T, Hara A, Arimura Y, Sada K-E, Makino H, and of of of Vasculitis W. Risk factors associated with relapse in Japanese patients with microscopic polyangiitis. J Rheumatol 2011;39:545\u201351.","journal-title":"The Journal of Rheumatology"},{"key":"1799_CR28","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/art.33361","volume":"64","author":"M Walsh","year":"2012","unstructured":"Walsh M, Flossmann O, Berden A, Westman K, H\u00f6glund P, Stegeman C, et al. Risk factors for relapse of antineutrophil cytoplasmic antibody\u2013associated vasculitis. Arthritis Rheum. 2012;64:542\u20138.","journal-title":"Arthritis Rheum"},{"key":"1799_CR29","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/acr.20176","volume":"62","author":"M Walsh","year":"2010","unstructured":"Walsh M, Merkel PA, Mahr A, Jayne D. Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis. Arthritis Care Res. 2010;62:1166\u201373.","journal-title":"Arthritis Care Res."},{"key":"1799_CR30","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1001\/jama.2009.1488","volume":"302","author":"DJ de Jager","year":"2009","unstructured":"de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009;302:1782\u20139.","journal-title":"JAMA"},{"key":"1799_CR31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ki.2013.279","volume":"85","author":"F Tentori","year":"2014","unstructured":"Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG, et al. High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int. 2014;85:166\u201373.","journal-title":"Kidney Int."}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-019-01799-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-019-01799-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-019-01799-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T10:37:04Z","timestamp":1664707024000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-019-01799-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1799"],"URL":"https:\/\/doi.org\/10.1007\/s10157-019-01799-2","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"11 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee at which the studies were conducted (IRB approval number 4370) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}